Skip to Main Content

Author Details

Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
1989
152
30
PMIDPaper TitleJournal TitlePublished Year
36753516Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.Inflamm Bowel Dis2024
38085938Editorial: Moving towards prognostic endoscopic scoring in IBD.Aliment Pharmacol Ther2024
37716860Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study.Dig Liver Dis2024
37949249Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.Gastroenterology2024
37933849Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-Analysis.J Crohns Colitis2024
37186256Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy.Inflamm Bowel Dis2024
37116893Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index.Inflamm Bowel Dis2024
37002875Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.Inflamm Bowel Dis2024
36219564Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies.J Crohns Colitis2023
37506265Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis.Inflamm Bowel Dis2023
37577798Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis.Eur J Gastroenterol Hepatol2023
37638216Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study.Saudi Pharm J2023
35672039Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Gui <i>et al</i>.Gut2023
35762666The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.Inflamm Bowel Dis2023
35421913The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis.Intest Res2023
35749316Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.Inflamm Bowel Dis2023
37391059Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.Clin Gastroenterol Hepatol2023
37317532Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.J Crohns Colitis2023
37119375Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.Dig Dis Sci2023
37316363The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review.Dig Liver Dis2023
37378711Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.Dig Dis Sci2023
36580497REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study.Am J Gastroenterol2023
36645636Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.Dig Dis Sci2023
36738443Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.J Crohns Colitis2023
36426810Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.Inflamm Bowel Dis2023
36708292Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis.Eur J Gastroenterol Hepatol2023
36731590Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.Clin Gastroenterol Hepatol2023
36528284Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study.Clin Gastroenterol Hepatol2023
36757156Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review.Am J Gastroenterol2023
36821429Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY study.J Crohns Colitis2023
35909369End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis.Scand J Gastroenterol2023
36001709Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical Research.J Crohns Colitis2023
36179118Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.Inflamm Bowel Dis2023
36271904Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.J Crohns Colitis2023
36066459Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study.Am J Gastroenterol2023
35930405Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis.J Crohns Colitis2023
36029969Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.Clin Gastroenterol Hepatol2023
36227009Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.J Clin Gastroenterol2023
35920382Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn's Disease.Inflamm Bowel Dis2023
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
36087074Beyond the White Pill: Advocating for Racial Diversity in IBD Trials.J Crohns Colitis2023
35880680Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease.Inflamm Bowel Dis2023
34329776Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35435862Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease.Am J Gastroenterol2022
35362140Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply.Aliment Pharmacol Ther2022
36397926Case Report: Managing Postoperative Crohn's Disease.Gastroenterol Hepatol (N Y)2022
36165053Pilot study of an elimination diet in adults with mild to moderate Crohn's disease.Eur J Gastroenterol Hepatol2022
33766910Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD).Gut2022
33838348Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease.Clin Gastroenterol Hepatol2022
35191100Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy.J Gastroenterol Hepatol2022
  • 1 - 50 of 152

Recommended Authors

Sunhee Park
University of California Irvine
Career Start Year 2014
Number of shared co-authors 4
Terrence C Lee
University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Vivek A Rudrapatna
University of California san francisco
Career Start Year 2012
Number of shared co-authors 4
Phillip Gu
Cedars-Sinai Medical Center
Career Start Year 2012
Number of shared co-authors 4
Gaurav Syal
university of california san diego
Career Start Year 2012
Number of shared co-authors 8
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 2
Christina Ha
Cedars-Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 8
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 1
Brendan Boyle
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 0
Berkeley N Limketkai
university of california los angeles School of Medicine
Career Start Year 2008
Number of shared co-authors 7
Jessica J Lee
Center for Drug Evaluation and Research
Career Start Year 2006
Number of shared co-authors 0
Michael Sey
Western University
Career Start Year 2006
Number of shared co-authors 3
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Jenny Sauk
university of california los angeles School of Medicine
Career Start Year 2004
Number of shared co-authors 10
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 2
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Career Start Year 2004
Number of shared co-authors 0
Nimisha K Parekh
University of California Irvine
Career Start Year 2001
Number of shared co-authors 7
Gil Y Melmed
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 2001
Number of shared co-authors 10
Florian Grimpen
Royal Brisbane and Women's Hospital
Career Start Year 2000
Number of shared co-authors 0
Uma Mahadevan
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 10
William A Faubion
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 7
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 5
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Joseph A Murray
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 7
Nghia H Nguyen
University of California
Career Start Year 1990
Number of shared co-authors 7
Dermot P B McGovern
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1987
Number of shared co-authors 9
Felicity T Enders
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 5
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 2
Nicholas J Talley
University of Newcastle
Career Start Year 1984
Number of shared co-authors 2
Phillip Fleshner
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1981
Number of shared co-authors 10

Collaborators

Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers 43
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 42
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers 30
Siddharth Singh
University of California San Diego
Co-authored papers 14
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
William J Sandborn
University of California San Diego
Co-authored papers 11
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Co-authored papers 9
Farhad Peerani
University of Alberta
Co-authored papers 6
Brigid S Boland
University of California
Co-authored papers 6
Dana J Lukin
Jill Roberts Center for IBD
Co-authored papers 5
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers 5
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers 5
Arun Swaminath
Lenox Hill Hospital
Co-authored papers 5
Eugenia Shmidt
University of Minnesota
Co-authored papers 5
David Hudesman
NYU Grossman School of Medicine
Co-authored papers 5
Sunanda V Kane
Mayo Clinic
Co-authored papers 5
Diana Whitehead
Dartmouth-Hitchcock Medical Center
Co-authored papers 4
Khadija Chaudrey
Lahey Hospital and Medical Center
Co-authored papers 4
Salim Yusuf
Co-authored papers 3
Mark S Silverberg
Co-authored papers 3
Robert Hirten
Co-authored papers 3
John T Chang
University of California San Diego
Co-authored papers 2
Christianne L Roumie
Vanderbilt University Medical Center
Co-authored papers 1
Ashish Atreja
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Stefan Schreiber
Co-authored papers 1
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 1
Ashwin N Ananthakrishnan
Co-authored papers 1
Marla C Dubinsky
Co-authored papers 1
Jagadish Rangrej
Ontario Ministry of Health and Long-Term Care
Co-authored papers 1
Shuang Wang
Shanghai Putuo People's Hospital, Tongji University
Co-authored papers 1
Release 1.2